To further investigate the anti-tumor activities mediated by EGFR downregulation in breast cancer cells, we examined the expression of c-myc and Nanog in MCF7 cells after co-treatment with tamoxifen and DCA. The gene discussed is NANOG; the disease is neoplasm.